Shah Preetam
Insider CIK 1787403 · BCLI EVP, CFO and Treasurer · ELTX See Remarks · CDTX Chief Financial Officer
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| ELTX Elicio Therapeutics, Inc. | A Award deriv | 2026-07-16 | 2026-07-17 | 60,833 | — | $0 | 60,833 | SEC↗ |
| ELTX Elicio Therapeutics, Inc. | A Award deriv | 2026-02-02 | 2026-02-03 | 47,900 | — | $0 | 47,900 | SEC↗ |
| ELTX Elicio Therapeutics, Inc. | A Award | 2026-02-02 | 2026-02-03 | 24,000 | — | $0 | 24,000 | SEC↗ |
| ELTX Elicio Therapeutics, Inc. | A Award deriv | 2025-04-15 | 2025-04-16 | 191,624 | — | $0 | 191,624 | SEC↗ |
| CDTX Cidara Therapeutics, Inc. | A Award deriv | 2024-09-30 | 2024-10-02 | 130,087 | — | $0 | 130,087 | SEC↗ |
| CDTX Cidara Therapeutics, Inc. | A Award deriv | 2024-03-15 | 2024-03-20 | 217,500 | — | $0 | 217,500 | SEC↗ |
| CDTX Cidara Therapeutics, Inc. | A Award | 2024-03-15 | 2024-03-20 | 108,750 | — | $0 | 335,960 | SEC↗ |
| CDTX Cidara Therapeutics, Inc. | S Sale | 2024-03-11 | 2024-03-12 | 18,931 | $0.67 | $12.7K | 227,210 | SEC↗ |
| CDTX Cidara Therapeutics, Inc. | A Award deriv | 2023-03-27 | 2023-03-29 | 180,000 | — | $0 | 180,000 | SEC↗ |
| CDTX Cidara Therapeutics, Inc. | A Award | 2023-03-27 | 2023-03-29 | 90,000 | — | $0 | 238,141 | SEC↗ |
| CDTX Cidara Therapeutics, Inc. | S Sale | 2023-03-13 | 2023-03-13 | 6,648 | $1.53 | $10.2K | 148,141 | SEC↗ |
| CDTX Cidara Therapeutics, Inc. | S Sale | 2022-09-19 | 2022-09-19 | 15,642 | $0.77 | $12.0K | 150,789 | SEC↗ |
| CDTX Cidara Therapeutics, Inc. | M Exercise deriv | 2022-09-15 | 2022-09-19 | 50,000 | — | $0 | 0 | SEC↗ |
| CDTX Cidara Therapeutics, Inc. | M Exercise | 2022-09-15 | 2022-09-19 | 50,000 | — | $0 | 166,431 | SEC↗ |
| CDTX Cidara Therapeutics, Inc. | A Award deriv | 2022-03-31 | 2022-04-04 | 102,500 | — | $0 | 102,500 | SEC↗ |
| CDTX Cidara Therapeutics, Inc. | A Award | 2022-03-31 | 2022-04-04 | 51,250 | — | $0 | 71,250 | SEC↗ |
| CDTX Cidara Therapeutics, Inc. | F Tax w/h | 2022-03-31 | 2022-04-04 | 24,820 | $0.83 | $20.6K | 112,431 | SEC↗ |
| CDTX Cidara Therapeutics, Inc. | A Award | 2022-03-31 | 2022-04-04 | 66,001 | — | $0 | 137,251 | SEC↗ |
| CDTX Cidara Therapeutics, Inc. | P Buy | 2021-11-12 | 2021-11-15 | 20,000 | $1.54 | $30.8K | 20,000 | SEC↗ |
| CDTX Cidara Therapeutics, Inc. | A Award deriv | 2021-09-01 | 2021-09-03 | 50,000 | — | $0 | 50,000 | SEC↗ |
| CDTX Cidara Therapeutics, Inc. | A Award deriv | 2021-09-01 | 2021-09-03 | 311,850 | — | $0 | 311,850 | SEC↗ |
| BCLI BRAINSTORM CELL THERAPEUTI | F Tax w/h | 2020-12-30 | 2020-12-31 | 25,000 | $4.64 | $116.0K | 11,600 | SEC↗ |
| BCLI BRAINSTORM CELL THERAPEUTI | P Buy | 2019-12-24 | 2019-12-27 | 11,600 | $3.96 | $45.9K | 36,600 | SEC↗ |
| BCLI BRAINSTORM CELL THERAPEUTI | A Award deriv | 2019-09-06 | 2019-09-09 | 100,000 | — | $0 | 100,000 | SEC↗ |
| BCLI BRAINSTORM CELL THERAPEUTI | A Award deriv | 2019-09-06 | 2019-09-09 | 100,000 | — | $0 | 100,000 | SEC↗ |
| BCLI BRAINSTORM CELL THERAPEUTI | A Award | 2019-09-06 | 2019-09-09 | 25,000 | — | $0 | 25,000 | SEC↗ |